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Purpose: The aim of the present work was to develop a nanocarrier-based formulation for topical delivery 
of resveratrol. 
Methods: Trans-resveratrol (t-res) was encapsulated in liposomes,  ethosomes or transferosomes, by a 
modified hand-shaking method followed by extrusion. All the formulations were characterised in terms of 
mean diameter, size distribution (I.P.), t-res loading, t-res stability upon encapsulation during storage. The 
nanocarriers containing t-res were then introduced in cellulose-based gel to allow their final administration 
on the skin and the viscoelastic properties of the resulting formulation were investigated. Finally, we 
studied the inhibition of reactive oxygen species (ROS) in human keratinocyte (HaCaT) cell line stimulated 
with H2O2 for 24 h and then incubated with the t-res containing nanocarriers. 
Results: All the t-res containing carriers were characterised by a very high (close to 100%) encapsulation 
efficiency, a negligible t-res release at 4°C and stability of resveratrol in its trans form. The carriers only 
slightly influenced the viscoelastic characteristics of cellulose-based gels. Nanocarriers encapsulating t-res 
reduced, in a concentration-dependent manner, ROS production induced by H2O2 and this effect was 
higher when using t-res-encapsulating nanocarrier, with the higher effect observed in the case of 
ethosomes. 
Conclusions: In this work nanocarriers with high encapsulation efficiency, high physical stability and 
negligible t-res release during storage at 4°C were prepared. To allow their final administration on the skin, 
the nanocarrier can be easilisy loaded in cellulose-based gels without altering its rheological properties. 
Moreover, the use of t-res-encapsulating ethosomes led to an efficient antioxidant activity. Further ex vivo 
and in vivo studies will clarify the role of the different carrier when administered on the skin. 
